Rx Spending Stands Out In CMS Projections – As Slowing Down
Executive Summary
Pharmaceutical industry’s message on overall drug spending trends is getting some timely support from the Center for Medicare and Medicaid Services’ annual national health expenditure projections.
You may also be interested in...
Sanofi's Drug Pricing Pledge Ties Increases To National Health Expenditure
While other companies have promised not to raise their drug prices beyond 10%, Sanofi is using the rate of medical inflation (expected to be 5.4% in 2017) in setting its annual list price hikes. Company retains option to increase prices beyond benchmark.
Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform
Rep. Tom Price and health policy consultant Seema Verma will spearhead Trump Administration efforts to reform the Affordable Care Act as HHS secretary and administrator of CMS, respectively.
US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight
Rate of growth in prescription drug spending is expected to average 6.7% per year from 2016 through 2025, National Health Expenditures report from CMS projects.